Kidney stone

Study Shows SGLT2 Inhibitors May Lower Risk of Kidney Stones in Adults with Type 2 Diabetes

A recent study published in JAMA Internal Medicine found that adults with type 2 diabetes may benefit from lower risk of nephrolithiasis by initiating SGLT2 inhibitors. The research compared the effects of different type 2 diabetes medications on the risk of developing kidney stones and found that SGLT2 inhibitors outperformed other medications in reducing the risk of nephrolithiasis. This finding could have significant implications for the treatment and management of type 2 diabetes, as kidney stones can be a serious complication for individuals with the condition.

SGLT2 Inhibitors May Lower Risk of Kidney Stones in Type 2 Diabetes Patients

Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit…